SLC25A28 and neoplasm: Next, using a xenograft model with MFRN1 low expressing human liver cancer cells, we observed that shRNA-mediated MFRN2 perturbation alone delayed tumor growth, which could be mitigated by forced overexpression of MFRN1 (Fig. 6e).